Treatment of onychomycosis in the diabetic patient population
- 22 February 2003
- journal article
- review article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 17 (2) , 98-104
- https://doi.org/10.1016/s1056-8727(02)00199-x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of lifeJournal of the American Academy of Dermatology, 1999
- Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care PopulationPharmacoEconomics, 1999
- Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernailJournal of the American Academy of Dermatology, 1998
- An Overview of Topical Antifungal Therapy in DermatomycosesDrugs, 1998
- Diagnostic techniques for confirming onychomycosisJournal of the American Academy of Dermatology, 1996
- Special patient populations: Onychomycosis in the diabetic patientJournal of the American Academy of Dermatology, 1996
- Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapyJournal of the American Academy of Dermatology, 1996
- Cutaneous manifestations of diabetes mellitusJournal of the American Academy of Dermatology, 1994
- Prevalence of dermatophytosis in patients with diabetesJournal of the American Academy of Dermatology, 1992
- Adverse Drug Reactions to Systemic Antifungals Prevention and ManagementDrug Safety, 1992